Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB4 versus Enbrel in rheumatoid arthritis despite methotrexate therapy
2012-005026-30Phase 3Completed
- Sponsor
- Samsung Bioepis
- Start
- Feb 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of etanercept in rheumatoid arthritis (RA) (2 arms), sponsored by Samsung Bioepis. Primary endpoint: ACR20 response at Week 24. Started Feb 2013; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-005026-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005026-30.